Companies /Healthcare
Zoetis Inc - Class A
NYSE: ZTS Drug Manufacturers - Specialty & Generic
$78.64
▲ $3.35 (+4.44%) today
Markets open · 1:49pm ET

Zoetis (ZTS) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+3.60%
Avg. EPS surprise
Consecutive EPS beats
ZTS vs Market · 30-day return after each reportZTSS&P 500
−6%0%+6%+12%+13.5%+7.2%Q1 25+4.9%+3.1%Q2 25−4.7%+1.6%Q3 25−3.2%−1.5%Q4 25−5.9%+0.8%Q1 26−4.8%−0.3%Q2 26
−6%0%+6%+12%Q1 25Q3 25Q1 26
ZTS EPS Trend · estimate vs actualEstimateActual
$0.00$0.60$1.20$1.80$1.40$1.48Q1 25$1.61$1.76Q2 25$1.62$1.70Q3 25$1.40$1.48Q4 25$1.62$1.53Q1 26$1.84$1.87Q2 26
$0.00$0.60$1.20$1.80Q1 25Q3 25Q1 26
ZTS Revenue Trend · estimate vs actualEstimateActual
$0$700.0M$1.4B$2.1B$2.2B$2.2BQ1 25$2.4B$2.5BQ2 25$2.4B$2.4BQ3 25$2.4B$2.4BQ4 25$2.3B$2.3BQ1 26
$0$700.0M$1.4B$2.1BQ1 25Q2 25Q3 25Q4 25Q1 26

How Often Does Zoetis Beat Earnings Estimates?

Zoetis beat EPS estimates in 5 of its last 6 reported quarters.

ZTS quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $1.87 est. $1.84 +1.63% $2.5B —
Q1 2026 $1.53 est. $1.62 −5.29% $2.3B est. $2.3B −1.70%
Q4 2025 $1.48 est. $1.40 +5.47% $2.4B est. $2.4B +1.08%
Q3 2025 $1.70 est. $1.62 +4.83% $2.4B est. $2.4B −0.23%
Q2 2025 $1.76 est. $1.61 +9.15% $2.5B est. $2.4B +2.18%
Q1 2025 $1.48 est. $1.40 +5.79% $2.2B est. $2.2B +1.24%

Figures from SEC filings and company reports. Not investment advice.